🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Experts discuss the evolving landscape of biomarker testing in HR+/HER2- metastatic #breastcancer and the role of liquid biopsy 👩‍⚕️ Watch a video of the conversation & download their slide set: cor2ed.com/precision-onco… Supported by an Independent Educational Grant from Thermo

👏NSCLC Literature review published in The Oncologist 👏 See the publication & download the slides ➡️ cor2ed.com/precision-onco… Authors: Prof. Frédérique Penault-Llorca & Prof. Mark Socinski Supported by an Independent Educational Grant from Bayer #MedEd #OncTwitter

How do #biomarker test results impact the management of pts w/ HR+/HER2- metastatic #breastcancer? Find out in this video podcast from precision oncology experts 📹 Highlights in this post video Tune in to the full conversation ⬇️ cor2ed.com/precision-onco… Supported by an

🧬Precision oncology on-demand webinar 🧬 #HER2 testing: The evolving role of immunohistochemistry (IHC) Profs. Fernando López-Ríos, Christian Rolfo & Charlie Gourley review data, guidelines, & pt cases as they explore - best practices for HER2 testing - the evolving role of

📢 Precision oncology e-learning Learn about HER2 testing: The evolving role of immunohistochemistry (IHC) In this e-learning programme, you’ll review data, guidelines, & patient cases, as you explore: - Best practices for HER2 testing - The evolving role of IHC in lung &

📣 #breastcancer video podcast! 📹 From Dr Rena Callahan & Dr Roberto Salgado ➡️ Exploring the latest insights in #moleculartesting and targeted therapy for HR+/HER2- metastatic breast cancer Listen on Spotify/Apple : cor2ed.com/precision-onco… Supported by an Independent

🚨#NSCLC update from #ASCO25! Expert insights on new data in oncogene-addicted NSCLC from: ➡️SOHO-01 & SOHO-02 ➡️SACHI ➡️OptiTROP-Lung03 ➡️HERTHENA-Lung02 📺Watch the video in this post to hear how Prof. Mark Socinski thinks these data could impact clinical practice See more

‘The evolving landscape of biomarker testing in HR+/HER2- metastatic #breastcancer and the role of liquid biopsy ’ A #MedEd video from renowned experts 📺 More info + downloadable slides 👉 cor2ed.com/precision-onco… Supported by an Independent Educational Grant from Thermo

Top Experts will Join COR2ED at #ASCO25 for Rapid Video Insights on Late-Breaking Data, stay tuned for some Great Insights LINK: buff.ly/He9wEAY In a series of short videos coming soon, Prof. Gerhardt Attard, first author on the AMPLITUDE study, will share

Join Leading Experts & COR2ED for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: buff.ly/He9wEAY Coming soon: a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE

Join Leading Experts & COR2ED for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: buff.ly/He9wEAY a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE study, Prof.

📢 On-demand webinar! ➡️#HER2 immunohistochemistry testing in #lungcancer & #ovariancancer w/ Profs. Fernando López-Ríos, Christian Rolfo & Charlie Gourley Watch the full webinar & download the experts’ slides 👇 cor2ed.com/precision-onco… Supported by an Independent Educational

Join Leading Experts & COR2ED for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: buff.ly/He9wEAY a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE study, Prof.

Catch up on highlights from #ASCO25! Experts joined us at ASCO to share their insights on how the latest data could change clinical practice ➡️ Prof. Mark Socinski: #NSCLC (downloadable slides also available) ➡️ Dr AttardLab: #ProstateCancer ➡️ Dr Lizzy Smyth: #GastricCancer

📣Advanced endometrial carcinoma video podcast #Obgyn experts discuss: - Molecular classification & treatment decisions - Evidence-based treatment selection - Shared decision-making Watch/listen 👉 cor2ed.com/obstetrics-gyn… This programme has been sponsored by Eisai Europe

When and how can HCPs use liquid biopsy for #biomarker testing in HR+/HER2- metastatic #breastcancer? ➡️Which biomarkers do you test for? ➡️How do you use test results effectively? Prof. Frédérique Penault-Llorca & Dr Aditya Bardia share their expert insights into this topic

Catch this ESMO Virtual Plenary 2025 update on the latest TROPION-Breast01 study with Prof. François-Clément Bidard & Dr Barbara Pistilli This study evaluates datopotamab deruxtecan (Dato-DXd) versus chemotherapy in previously treated, inoperable or metastatic HR+/HER2– breast

How is molecular classification transforming prognosis and personalising treatment in endometrial cancer? Find out here: cor2ed.com/obstetrics-gyn… #MedEd #Oncology #PrecisionMedicine #OBGYN This educational programme is sponsored by an Independent Educational Grant from Eisai

🧬 Precision oncology in HR+/HER2- metastatic breast cancer Experts discuss: - Essential biomarkers (ESR1m, PIK3CA, gBRCA) and their clinical implications - Liquid vs tumour biopsy – when and how? - Single gene vs broad panel testing …and much more 📹 Watch the video

Explore an expert-led infographic on best practices for pre-analytical handling in gastric, prostate & lung cancer Ensure accuracy when you conduct molecular profiling 👉 cor2ed.com/precision-onco… #CancerDiagnostics #Pathology 📷 This educational programme is supported by an